Atrial fibrillation and silent stroke: links, risks, and challenges

Area of Science:

• Cardiology
• Neurology
• Epidemiology

Background:

• Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with increasing prevalence due to Western population aging.
• AF significantly elevates mortality and morbidity, contributing to one-third of all strokes, which are often severe due to their thromboembolic nature.
• Silent brain infarction, asymptomatic cerebral infarction, is increasingly diagnosed due to imaging advancements, but its frequency, risk factors, and clinical relevance in AF remain unclear.

Purpose of the Study:

• To review diagnostic advancements for silent brain infarction (SBI).
• To explore the relationship between AF and SBI.
• To discuss the implications for stroke prevention strategies in AF patients.

Main Methods:

• Literature review of epidemiological studies and imaging advancements.
• Analysis of the prevalence and incidence of SBI in AF patients.
• Examination of current stroke prevention guidelines and research gaps.

Main Results:

• AF patients exhibit a higher prevalence of SBI compared to non-AF individuals.
• High incidence rates of SBI have been observed post-AF ablation procedures.
• The efficacy of anticoagulatory treatment in preventing SBI in AF patients is not well-established.

Conclusions:

• Silent brain infarction is a significant concern in atrial fibrillation patients.
• Further research is needed to clarify the role of anticoagulation in preventing SBI in AF.
• Improved diagnostic approaches and targeted preventive strategies are crucial for managing AF-related neurological complications.